Paula Peyrani

6.2k total citations
137 papers, 3.5k citations indexed

About

Paula Peyrani is a scholar working on Epidemiology, Infectious Diseases and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Paula Peyrani has authored 137 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Epidemiology, 31 papers in Infectious Diseases and 23 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Paula Peyrani's work include Pneumonia and Respiratory Infections (85 papers), Respiratory viral infections research (34 papers) and Pneumocystis jirovecii pneumonia detection and treatment (33 papers). Paula Peyrani is often cited by papers focused on Pneumonia and Respiratory Infections (85 papers), Respiratory viral infections research (34 papers) and Pneumocystis jirovecii pneumonia detection and treatment (33 papers). Paula Peyrani collaborates with scholars based in United States, Italy and United Kingdom. Paula Peyrani's co-authors include Julio A. Ramírez, Timothy L. Wiemken, Francesco Blasi, Stefano Aliberti, José Bordón, Forest W. Arnold, Mehdi Mirsaeidi, Marcus Zervos, Kimbal D. Ford and Daniel H. Kett and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Paula Peyrani

127 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paula Peyrani United States	31	2.5k	712	665	636	469	137	3.5k
Catia Cillóniz Spain	42	3.8k 1.5×	789 1.1×	1.3k 1.9×	589 0.9×	958 2.0×	183	5.5k
Núria Sabé Spain	30	2.1k 0.8×	512 0.7×	539 0.8×	355 0.6×	305 0.7×	64	2.9k
R. Verdaguer Spain	31	1.8k 0.7×	523 0.7×	693 1.0×	350 0.6×	368 0.8×	56	2.8k
María Ángeles Marcos Spain	41	4.4k 1.7×	1.5k 2.2×	985 1.5×	707 1.1×	796 1.7×	180	6.4k
Jordi Dorca Spain	44	3.5k 1.4×	606 0.9×	1.1k 1.7×	665 1.0×	1.6k 3.5×	143	5.5k
Thiago Lisboa Brazil	31	2.0k 0.8×	367 0.5×	1.4k 2.1×	376 0.6×	689 1.5×	110	3.3k
Scott A. Flanders United States	30	2.3k 0.9×	907 1.3×	758 1.1×	544 0.9×	1.0k 2.2×	85	5.4k
Werner C. Albrich Switzerland	32	2.0k 0.8×	881 1.2×	522 0.8×	224 0.4×	449 1.0×	138	3.8k
Florent Wallet France	32	1.3k 0.5×	632 0.9×	865 1.3×	225 0.4×	941 2.0×	167	3.2k
Edward Septimus United States	30	2.3k 0.9×	1.4k 2.0×	792 1.2×	303 0.5×	363 0.8×	110	5.1k

Countries citing papers authored by Paula Peyrani

Since Specialization

Citations

This map shows the geographic impact of Paula Peyrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Peyrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Peyrani more than expected).

Fields of papers citing papers by Paula Peyrani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Peyrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Peyrani. The network helps show where Paula Peyrani may publish in the future.

Co-authorship network of co-authors of Paula Peyrani

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Peyrani. A scholar is included among the top collaborators of Paula Peyrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Peyrani. Paula Peyrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martinón‐Torres, Federico, Ignacio Salamanca de la Cueva, Jason D. Maguire, et al.. (2025). Safety, tolerability, and immunogenicity of pentavalent meningococcal MenABCWY vaccine in healthy infants: A phase 2b randomized clinical trial. Human Vaccines & Immunotherapeutics. 21(1). 2463194–2463194.

Fergie, Jaime, Gary S. Marshall, Jana Shaw, et al.. (2025). Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination. Infectious Diseases and Therapy. 14(7). 1381–1403.

Martinón‐Torres, Federico, Mika Rämet, Ryan Newton, et al.. (2025). A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix® Vaccine When Given to Healthy Infants at 3 and 12 Months of Age. Infectious Diseases and Therapy. 14(2). 463–481.

Peterson, James T., Jason D. Maguire, Roger Maansson, et al.. (2024). Randomized trial showing persistence of hSBA titers elicited by a pentavalent meningococcal MenABCWY vaccine for up to 4 years following a primary series and safety and immunogenicity of a booster dose. Vaccine. 43(Pt 1). 126469–126469.

Snow, Vincenza, Alejandro Cané, Paula Peyrani, et al.. (2023). 1146. Cost-effectiveness of the Pentavalent Meningococcal Vaccine (MenABCWY): A steady-state cohort modelling approach. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Beeslaar, Johannes, Susan Mather, Judith Absalon, et al.. (2022). Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older. Vaccine. 40(12). 1872–1878. 2 indexed citations

Klein, Nicola P., Paula Peyrani, Kari Yacisin, et al.. (2021). A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age. Vaccine. 39(38). 5428–5435. 53 indexed citations

Peyrani, Paula, Forest W. Arnold, José Bordón, et al.. (2019). Incidence and Mortality of Adults Hospitalized With Community-Acquired Pneumonia According to Clinical Course. CHEST Journal. 157(1). 34–41. 29 indexed citations

Hurt, Ryan T., et al.. (2017). Impact of obesity on mortality in hospitalized patients with pneumonia due to 2009 H1N1 Influenza A virus versus other etiologies.. 1(3). 1 indexed citations

10.

Bosson, Rahel, Ruth Carrico, Anupama Raghuram, et al.. (2017). Refugee-Centered Medical Home: A New Approach To Care at the University of Louisville Global Health Center. 1(1). 3 indexed citations

11.

Wiemken, Timothy L., William A. Mattingly, Stephen Furmanek, et al.. (2017). Impact of temperature relative humidity and absolute humidity on the incidence of hospitalizations for lower respiratory tract infections due to influenza, rhinovirus, and respiratory syncytial virus: results from Community-Acquired Pneumonia Organization (CAPO) International Cohort Study.. ThinkIR: The University of Louisville's Institutional Repository (University of Louisville). 1(3). 3 indexed citations

12.

Panchabhai, Tanmay S., Raul Nakamatsu, Forest W. Arnold, et al.. (2016). Comparing posteroanterior with lateral and anteroposterior chest radiography in the initial detection of parapneumonic effusions. The American Journal of Emergency Medicine. 34(12). 2402–2407. 5 indexed citations

13.

Luna, Carlos M., et al.. (2016). The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia. Annals of the American Thoracic Society. 13(9). 1519–1526. 76 indexed citations

14.

Carugati, Manuela, Fabio Franzetti, Timothy L. Wiemken, et al.. (2015). De-escalation therapy among bacteraemic patients with community-acquired pneumonia. Clinical Microbiology and Infection. 21(10). 936.e11–936.e18. 32 indexed citations

15.

Peyrani, Paula, et al.. (2014). Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP). European Respiratory Journal. 44(Suppl 58). 4642–4642. 1 indexed citations

16.

Panchabhai, Tanmay S., Raul Nakamatsu, Forest W. Arnold, et al.. (2011). Computed tomography measurements of parapneumonic effusion indicative of thoracentesis. European Respiratory Journal. 38(6). 1406–1411. 14 indexed citations

17.

Bordón, José, et al.. (2010). Decrease in Long-term Survival for Hospitalized Patients With Community-Acquired Pneumonia. CHEST Journal. 138(2). 279–283. 85 indexed citations

18.

Aliberti, Stefano, John Myers, Paula Peyrani, et al.. (2008). The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia. European Respiratory Journal. 33(1). 142–147. 9 indexed citations

19.

Arnold, Forest W., James T. Summersgill, A. Scott LaJoie, et al.. (2007). A Worldwide Perspective of Atypical Pathogens in Community-acquired Pneumonia. American Journal of Respiratory and Critical Care Medicine. 175(10). 1086–1093. 169 indexed citations

20.

Patel, Alpa V., Raul Nakamatsu, RD Smith, et al.. (2007). Establishing a hospital program to improve antimicrobial use, control bacterial resistance and contain healthcare costs: the University of Louisville experience.. PubMed. 105(9). 431–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact